Abstract

Understanding the mechanisms regulating cell cycle, proliferation and potency of pluripotent stem cells guarantees their safe use in the clinic. Embryonic stem cells (ESCs) present a fast cell cycle with a short G1 phase. This is due to the lack of expression of cell cycle inhibitors, which ultimately determines naïve pluripotency by holding back differentiation. The canonical Wnt/β-catenin pathway controls mESC pluripotency via the Wnt-effector Tcf3. However, if the activity of the Wnt/β-catenin controls the cell cycle of mESCs remains unknown. Here we show that the Wnt-effector Tcf1 is recruited to and triggers transcription of the Ink4/Arf tumor suppressor locus. Thereby, the activation of the Wnt pathway, a known mitogenic pathway in somatic tissues, restores G1 phase and drastically reduces proliferation of mESCs without perturbing pluripotency. Tcf1, but not Tcf3, is recruited to a palindromic motif enriched in the promoter of cell cycle repressor genes, such as p15Ink4b, p16Ink4a and p19Arf, which mediate the Wnt-dependent anti-proliferative effect in mESCs. Consistently, ablation of β-catenin or Tcf1 expression impairs Wnt-dependent cell cycle regulation. All together, here we showed that Wnt signaling controls mESC pluripotency and proliferation through non-overlapping functions of distinct Tcf factors.

Highlights

  • Wnt/β-catenin signalling plays an essential role in development, tissue homeostasis and cancer [1]

  • All together our results show that, in contrast to its mitogenic effect in somatic cells, the Wnt/β-catenin pathway triggers an anti-proliferative effect in mouse embryonic stem cells (mESCs) via Tcf1 activity

  • We performed comparative gene target analysis of the two most expressed T cell factor/lymphoid enhancer factor (Tcf/Lef) factors in mESCs, Tcf1 and Tcf3 [10,14], by chromatin immunoprecipitation combined with DNA sequencing (ChIP-Seq)

Read more

Summary

Introduction

Wnt/β-catenin signalling plays an essential role in development, tissue homeostasis and cancer [1]. Activation of the Wnt pathway maintains pluripotency in mouse embryonic stem cells (mESCs) [2] and controls somatic cell reprogramming [3,4]. Deregulation or constant activation of Wnt signalling may lead to cancer formation [5]. Binding of Wnt ligands to their receptors results in the inactivation of the destruction complex, thereby allowing hypophosphorylated β-catenin accumulation [6]. Small molecules such as 6-bromoindirubin-3’-oxime (BIO) [7] or CHIR99021 [8] can be used to inhibit GSK3 and to stabilize β-catenin

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call